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Abstract
Polypyrimidine-tract binding protein 1 (PTBP1) is an important cellular regulator of messenger RNAs influencing the
alternative splicing profile of a cell as well as its mRNA stability, location and translation. In addition, it is diverted by some
viruses to facilitate their replication. Here, we used a novel PTBP1 knockout mouse to analyse the tissue expression pattern
of PTBP1 as well as the effect of its complete removal during development. We found evidence of strong PTBP1 expression
in embryonic stem cells and throughout embryonic development, especially in the developing brain and spinal cord, the
olfactory and auditory systems, the heart, the liver, the kidney, the brown fat and cartilage primordia. This widespread
distribution points towards a role of PTBP1 during embryonic development. Homozygous offspring, identified by PCR and
immunofluorescence, were able to implant but were arrested or retarded in growth. At day 7.5 of embryonic development
(E7.5) the null mutants were about 5x smaller than the control littermates and the gap in body size widened with time. At
mid-gestation, all homozygous embryos were resorbed/degraded. No homozygous mice were genotyped at E12 and the
age of weaning. Embryos lacking PTBP1 did not display differentiation into the 3 germ layers and cavitation of the epiblast,
which are hallmarks of gastrulation. In addition, homozygous mutants displayed malformed ectoplacental cones and yolk
sacs, both early supportive structure of the embryo proper. We conclude that PTBP1 is not required for the earliest
isovolumetric divisions and differentiation steps of the zygote up to the formation of the blastocyst. However, further post-
implantation development requires PTBP1 and stalls in homozygous null animals with a phenotype of dramatically reduced
size and aberration in embryonic and extra-embryonic structures.
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Introduction
Mouse embryonic development lasts about 3 weeks in total.
During the first days after fertilization the embryo does not grow
significantly in size, remaining at around 0.1 mm in diameter, and
differentiates only into 2 tissue types, the outside trophoblast and
the inner cell mass. The number of embryonic cells grows
exponentially to,70 at the time of implantation with concomitant
decrease in volume per cell.
Implantation at about day 4.5 of embryonic development
(E4.5) [1] marks a change in pace. After this point, the volume of
the embryo increases exponentially from ,0.2 mm in length at
E4.5 to 0.7–0.8 at E7.5. In the process embryonic tissues rapidly
reshape and differentiate. At E5.5, the compact embryo forms a
cavity and turns into the egg cylinder. A day later at E6.5,
gastrulation begins with the formation of the primitive streak in
the posterior region of the epiblast. Briefly afterwards the 3
germ layers, ectoderm, mesoderm and definitive endoderm, are
formed [2]. This marks the beginning of major differentiation
events.
Before implantation the embryo depends mostly on its own
reserves, while implantation represents a transition from internal
to external supply. The embryo and maternal cells form early
supportive structures like the yolk sac, the ectoplacental cone and
eventually the placenta, which nourishes the embryo and induces
adaptation in maternal cells [3]. Similarly, gene expression
switches from preloaded maternal to embryonic mRNAs. In mice
this maternal to zygotic transition lies relatively early at around the
2-cell stage or E1. RNA-binding proteins, like PTBP1, influence
both splicing of pre-mRNAs as well as their stability and
translation into protein.
PTBP1 (also known under the non-standard names PTB and
hnRNP I) is a nucleic acid binding protein, mainly known for its
role in multiple aspects of mRNA life cycle and function. These
include regulation of splicing [4–9], 39-end processing [10,11],
internal ribosomal entry site-mediated translation [12–14],
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localization [15,16] as well as stability and translation [17–21].
PTBP1 may also bind DNA [22] and act as a transcription factor
[23,24].
PTBP1 is a member of a larger family of 4 currently known
genes in mammals: PTBP1 [25], PTBP2 [26], ROD1 [27] and
smPTB [28]. Mammalian PTBP1 is broadly expressed and the best
studied gene in the group. PTBP2 (nPTB) is synthesised especially
by neuronal cell types. ROD1 has been detected in rat
hematopoietic cells, while smPTB is expressed in smooth muscle.
The Drosophila orthologue of PTBP1 is hephaestus, which in the
oocyte is part of the oskar mRNA-localising complex where it
represses its translation [17]. Later, during fly embryo develop-
ment it is expressed in mesodermal and neuronal lineages as well
as the imaginal discs and the adult germline [29].
According to structural data [30–33] PTBP1 contains 4 RNA-
binding domains. These domains belong to the RNA recognition
motif (RRM) family, one of the most abundant nucleic acid-
binding domains [34]. RRMs of different proteins bind 2–8
nucleotides with the RRMs of PTBP1 binding 3–5 with slightly
different sequence preference [35]. Multiple RRMs in a single
protein increase overall affinity and specificity.
Members of the PTBP family cross-regulate each other. Besides
regulating its own levels by exon suppression leading to nonsense-
mediated decay [4], PTBP1 suppresses PTBP2 via a similar
mechanism [5,6]. When PTBP1 levels are reduced, PTBP2 levels
are often upregulated. This hand-over causes a broad shift in
splicing and is critical for neuronal differentiation [5,6]. Reduction
of PTBP1 by RNAi in HeLa cells did not significantly
changeprotein levels except for the release of PTBP2 suppression,
which demonstrates the redundancy between these proteins. Only
when both were reduced did protein levels for several genes
change, including the release of ROD1 suppression [7].
In order to investigate the function of PTBP1 in a complex
organism, we set out to generate a mouse multi-functional allele.
In this manuscript we report the developmental expression pattern
of PTBP1 as detected with the reporter gene introduced into this
allele as well as the effect of its systemic knockout.
Results
A novel multi-purpose allele for PTBP1
Using Red/ET homologous recombination [36] we generated a
novel PTBP1 allele (Figure 1, Figure S1), which in its original state
causes a systemic knockout and produces bacterial b-galactosidase
(LacZ) for detection of expression from the PTBP1 locus. We
verified the efficiency of the transcriptional block using RT PCR
(Figure S2). The stop/detection cassette can be removed with FLP
recombinase leading to an allele indistinguishable from the wild-
type except for the presence of loxP sites flanking exons 3 to 7. In
the last stage of the multi-purpose allele, this group of exons can be
removed by Cre recombination, leading to a premature stop
codon and a null mutation of PTBP1.
Figure 1. Generation of a mouse containing a novel multipurpose PTBP1 allele. We generated a multipurpose PTBP1 allele and targeted it
into mice. A) The wild-type locus (blue) was modified with the insertion of a stop/detection cassette (red) into embryonic stem cells. The cassette can
be flipped out using an FLP recombinase construct or strain. In addition, exons 3 to 7 have been framed with loxP sites for conditional removal by a
Cre recombinase. The diagram indicates the Southern strategy as well as the location of the primers for validation of the construct and genotyping. B)
shows the results of the long-range PCR to verify the 59 junction resulting from the homologous recombination of the targeting vector with the wild-
type PTBP1 locus. C) Southern blot to verify the correct 39 junction in the mutant allele.
doi:10.1371/journal.pone.0016992.g001
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Broad expression of PTBP1 during gestation
In order to gauge the importance of PTBP1 in embryonic
development, we performed X-gal staining of heterozygous
embryonic stem cells (ESCs) and heterozygous whole embryos at
equal time intervals between implantation at E4-4.5 and birth at
E20-21 (Figure 2). PTBP1 displayed a striking expression pattern
in E6.5 and E7.5 basically labelling the epiblast. In E6.5, we
observed PTBP1 reporter in visceral endoderm but not in yolk sac
mesoderm, chorionic ectoderm or the ectoplacental cone.
Heterozygous but not wild-type decidua expresses PTBP1 in the
area surrounding the epiblast. Since X-gal only penetrates 1–
2 mm into tissue, we performed X-gal staining on cryosections in
addition to whole mount preparations for E12.5 and E16.5.
Accordingly, the LacZ signal in the skin was very strong in whole
mount preparations (Figure S3), but barely detectable in the
cryosections (Figure 2), which instead revealed strong PTBP1
expression in developing internal organs and tissues such the brain
cortex and subventricular zone, where neuronal precursors are
found, the trigeminal ganglion, the nasal cavity, the inner ear, the
medulla oblongata, the spinal cord, the thyroid, the heart, the
lung, the kidney, possibly the pituitary and several cartilage
primordia but not more ossified structures (see especially the E16.5
rib sections in Figure 2). PTBP1 expression became more restricted
with increasing embryonic age. While the E8.5 embryo was almost
completely stained by X-gal, the signal became more differentiated
in E12.5 and E16.5. We conclude that PTBP1 is strongly and
broadly expressed during the entire gestational period and in the
cultured embryonic stem cells used to generate this knockout
mouse model.
PTBP1 null embryos implant but are severely growth-
retarded
To gain insight into the function of PTBP1, we analyzed the
progeny of mice heterozygous for the PTBP1 multipurpose allele.
We noted that the average heterozygous/heterozygous litter of
7.061.7 standard deviation was smaller than a heterozygous/wild-
type cross with 8.2+/22.2. Genotyping at weaning revealed the
absence of homozygous offsprings and a 0.57 ratio between wild
and heterozygous (Table 1). This data indicated that PTBP1 null
mutants are embryonically lethal and thereby that this gene is
essential for development.
To establish at which stage the lack of PTBP1 stalls embryonic
development we isolated embryos working backward from E12.5.
At this time 2 types of implantations were visible: small degraded
and normally sized. Going further backward in development we
were able to observe small implantations at E6.5, E7.5, and E8.5
(Table 1), the last time point examined at which small embryos still
showed cellular structure and were not yet degraded. At E7.5, we
quantified the area of the largest embryo cross-section. The small
embryos were on average 0.02 mm2, significantly smaller than the
large embryos with 0.11 mm2 (Figure 3). In 2 litters we observed 3
small embryos and 10 large embryos (ratio 0.3) and 2 empty
deciduas.
In order to ascertain the nature of the small implantations, we
isolated embryos at E7.5, carefully avoiding contamination from
the maternal decidua which would have biased the resulting
genotype towards heterozygous. We analysed 5 small and 17 large
embryos by PCR. All 5 small embryos were genotyped as
homozygous for the PTBP1 knockout allele, 15 large embryos
were either wild-type or heterozygous, with 2 large embryos being
misclassified as homozygous probably due to problems in the
intron PCR (Figure 4 and Table 1).
We confirmed the hypothesis that small embryos are homozy-
gous by immunofluorescence staining with a PTBP1 antibody
(Figure 4). All small embryos at E7.5 showed only background
level of PTBP1 signal from the embryonic tissue while showing
normal nuclear fluorescence from surrounding maternal hetero-
zygous decidual cells. There was, however, unspecific staining in
the yolk sac membrane due to the use of a mouse monoclonal
antibody. Together with the PCR data this establishes that
homozygous embryos are severely growth retarded compared to
their littermates.
Null embryos are not able to begin cavitation or properly
form the yolk sac and the ectoplacental cone
A wild-type embryo at E7.5 has formed an ectoplacental cone
invaded by maternal blood [3] and has surrounded itself with a
yolk sac (Figure 5a). The latter structure is cooperatively build by
parietal endoderm forming a thick basement membrane (the
Reichert’s membrane) and trophoblast giant cells on the embryo
side, as well as maternal blood and decidual cells on the outside
[37]. In many homozygous mutant embryos the yolk sac was not
clearly separated from the epiblast. Also, the Reichert’s membrane
was not properly formed and contained unusual quantities of
eosinophilic material (Figure 5a). Similarly, the ectoplacental cone
did not properly form, often lacking the characteristic connection
of decidual cells, giant cell, the Reichert’s membrane and parietal
cells. A typical embryo is enveloped in visceral endodermal cells,
which are subdivided into cuboidal cells with characteristic apical
vacuoles and squamous cells that differentiate later. Even in the
most advanced homozygous mutant at E7.5, the squamous
endodermal cells were not visible showing a delay in the formation
of the visceral yolk sac.
To look in more detail at the molecular composition of control
and mutant membranes, we performed immunofluorescence on
embryo cryosections (Figure 5b) for collagen 4, which is an
abundant and essential structural component of the basement
membrane [38]. Normal embryos (wild-type or heterozygous)
showed a strong collagen 4 signal from the Reichert’s membrane
as well as the basement membrane underlying the visceral
endoderm. On the other hand, embryos lacking PTBP1 had a
massively increased area high in collagen surrounding a small
spherical area containing little or no collagen, which might
represent the embryo proper.
We speculate that since the developing placenta and the
growing yolk sac nourish the embryo and are involved in signalling
processes, null embryos may be starved and insufficiently
stimulated to grow and develop.
PTBP1 knockouts do not complete stages of early
development including cavitation and gastrulation
In normal embryos starting at,E5, the epiblast hollows to form
a central cavity which at E7.5 is subdivided into the ectoplacental,
the exocoelomic, and the amniotic cavity. Cavitation becomes
easily discernible in sections at E6. We never observed cavitation
in thin sections of a dozen homozygous PTBP1 null embryos at
E7.5 (Figure 4b, 5). These embryos did not show any of the 3
characteristic cavities for this stage. In only a few null embryos an
unusually small yolk sac space was visible.
In normal mouse embryos gastrulation begins at,E6.5 with the
formation of the primitive streak in the posterior side of the
hollowed epiblast. Cells separate into the 3 germ layers. Most null
embryos were so malformed that early cell types like ectoderm and
endoderm could not be discerned (Figure 4b, 5). Only very few
homozygous embryos showed partial separation of cell layers like
KO1 in Figure 4b. To further investigate the molecular
underpinning of development in the null mutants, we performed
PTBP1 Is Required for Embryonic Development
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Figure 2. PTBP1 is expressed throughout embryonic development. The LacZ reporter shown in Figure 1 was used here as a proxy for PTBP1
promoter activity in heterozygous embryonic stem cells (ESCs) and embryos at different stages of development. PTBP1 expression was high in ESCs.
In embryos 6.5 days after fertilisation (E6.5), PTBP1 was expressed especially in the epiblast but also in the visceral endoderm surrounding the embryo.
The expression pattern was similar at E7.5 where the activation of maternal PTBP1 was seen in the decidua surrounding the tip of the embryo. No
LacZ staining was observed in the wild-type (wt) littermate (small inlet). The reporter was expressed in almost all cells at E8.5 and in most cells at E9,
when only the areas at the roof of the future head, the primitive ventricle of the heart, and some structures in the tail appeared to express little or no
PTBP1. In E12.5 embryos most developing tissues and organs expressed the reporter, most notably the cells lining the ventricles of the brain, the
spinal cord, the pituitary and the heart. Similar organs were stained in E16.5 embryos and in addition the nasal cavities, the inner ear and the brown
PTBP1 Is Required for Embryonic Development
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RT PCR for T/brachyury on mutant versus control embryos. T is
an embryonic transcription factor expressed in the primitive streak
during gastrulation. T was consistently detected in normal
embryos but absent in all small mutant embryos while a control
RT PCR was positive for all samples (Figure 6).
We interpret the absence of cavities, the predominant lack of
germ layers, and the failure to activate the gastrulation marker T
as an indication that PTBP1 null embryo at E7.5, although viable,
are no longer following the normal developmental programme.
The systemic, homozygous ablation of PTBP1 is
embryonically lethal before E12
We determined the genotype of embryos born from heterozy-
gous parents using whole embryo, yolk sac, or tail clip PCR
depending on the size of the animal. In addition, we distinguished
between embryos expressing PTBP1 from the null mutants using
immunofluorescence on cryosections. The results, summarised in
Table 1, show that homozygous mutant embryos were viable
during the first days following implantation but were no longer
detected at around mid-gestation. At E12, E16, and the time of
weaning, no homozygous animals could be detected by PCR. At
the former time points, small deciduas often contain degraded
material at their centre that can be neither genotyped nor
sectioned. Hence, it appears that after diverging from normal
development shortly after implantation, the lack of PTBP1
becomes lethal shortly after E8.5 and before E12.
No compensation from PTBP2 or Rod1 in PTBP1 KO
embryos
PTBP1 suppresses the expression of PTBP2, which is 70%
identical in amino acid sequence and fulfils similar functions. In
adult tissues, downregulation of PTBP1 often causes upregulation
of PTBP2. We were therefore asking ourselves whether a similar
compensation could be at work in the PTBP1 knockout embryos.
Control embryos expressed both paralogues, albeit with a different
distribution. PTBP1, apart from surrounding decidual cells was
highly expressed in the visceral endoderm and the epiblast. This is
in agreement with the expression pattern revealed with the LacZ
reporter assay (Figure 2). In E7.5 embryos, the strongest PTBP2
fluorescence was found in the epiblast only. However, null mutants
showed neither PTBP1 nor PTBP2 immunofluorescent signals at
E7.5 (Figure 7). We also looked at whether the 3rd, lesser known
paralogue of the PTBP group, Rod1, is upregulated in PTBP1 null
embryo. Using RNA extracts from E7.5 embryos, we performed
RT PCR and did not detect any amplification in the knockout or
the control embryos (Figure S5).
We conclude that mutant embryos are not able to compensate
for the ablation of PTBP1 with the upregulation of PTBP2 or Rod1.
PTBP1 suppresses PTBP2 by exclusion of an essential exon and
the upregulation of PTBP2 after reduction of PTBP1 requires an
active PTBP2 promoter. It may be that the PTBP1 knockout in
embryos does not cause upregulation of PTBP2 because the cells
are so fundamentally perturbed that the PTBP2 gene is never
activated.
Reduced proliferation and apoptosis in mutant embryos
To take a more detailed look at cell proliferation in embryos
lacking Ptbp1 versus those containing either 1 or 2 normal alleles,
we performed BrdU and TUNEL assays (Figure 8). As estimated
by BrdU incorporation into newly synthesised DNA, cell division
was high throughout the control E7.5 embryos analysed, with
especially strong signal coming from the epiblast, the visceral
endoderm, the area of the yolk sac, and the ectoplacental cone.
Interestingly, the epiblast and the endoderm were also labelled
strongly using Ptbp antibodies (Figure 7). There appears to be a
correlation between the expression levels of Ptbps and cell division
in embryos. Also, null mutants clearly synthesise less DNA.
We detected no TUNEL in control embryos while large parts of
the knockout embryos showed DNA fragmentation, indicative of
apoptosis (Figure 8, bottom). It appears that after about a week of
gestation homozygous Ptbp1 null cells are beginning to apoptose.
Discussion
PTBP1 is necessary for early post-implantation
development
We generated a new, multi-purpose PTBP1 allele which was
used, in its first stage, to analyse the effect of a systemic knockout.
Dissecting pregnancies at several stages, we identified 2 popula-
tions of embryos - one with the expected size for the stage of
embryonic development and another of smaller size. The
difference between the populations was visible as early as E6.5
and widened until the degradation of the small implantation set in
after E8.5. Small embryos did not grow significantly after
implantation. Genotyping and immunostaining of both embryo
populations for PTBP1 lead us to identify the small population as
the homozygous knockout of PTBP1. We therefore conclude that
PTBP1 is essential for cell division after implantation, which,
unlike earlier mitosis, is associated with significant increase in the
cell mass of the embryo.
After characterising the small embryos as homozygous KOs, we
analyzed in detail the histology of null embryos at E7.5 and
Table 1. Survival of PTBP1 null mutants.
genotype ratio PCR ratio IF
age method wt het hom
wt/
het
hom/
het
hom/
het+wt
E6.5 IF 19 5 0.26
E7.5 PCR 5 12 5 0.42 0.42
E7.5 IF 3 3 1.00
E8.5 IF 7 2 0.29
E12.5 PCR 8 17 0 0.47 n/a
E16.5 PCR 1 3 0 0.33 n/a
3 weeks PCR 25 44 0 0.57 n/a
expect: 0.50 0.50 0.33
The table summarises the genotype of embryos during gestation as determined
by PCR or immunofluorescence (IF), the latter of which cannot distinguish
between wild-type (wt) and heterozygous (het). The last viable homozygous
(hom) embryos were detected at day 8.5 of embryonic development (E8.5). No
homozygous mutants were found at E12.5 or later. Genotype ratios observed
and expected are shown on the right. While they are close to the expected
Mendelian ratio for experiment with several litters, random variations and
deviation from the expected ratios are larger in single litter experiments.
doi:10.1371/journal.pone.0016992.t001
fat pad on the back of the embryo. PTBP1 was high in the ventral rib cartilage but much lower in the dorsal rib bones that already showed a central
cavity. While at E12.5 there was no unspecific staining, at E16.5 the intestine and to a lesser degree the stomach displayed an X-gal signal not due to
the PTBP1 reporter. The signal result from endogenous b-galactosidase. See Figure S3 for a whole-mount LacZ at E12 and E16.
doi:10.1371/journal.pone.0016992.g002
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observed that most mutant embryos were not able to commence
cavitation or form the 3 germ layers. They also were not able to
induce expression of T/brachyury, a transcription factor required
for the formation of the primitive streak early in gastrulation. This
indicates that PTBP1 is necessary to go through the early post-
implantational processes, involving the formation of the egg
cylinder and gastrulation.
Null embryos also showed malformed yolk sac and placental
structures, often with no discernible yolk sac cavity, an unusually
thickened, eosinophilic membrane and giant cells not in their
typical position between the Reichert basement membrane and
the decidua. A properly formed yolk sac together with early
placental structures supplies the embryo with nutrients and enables
signalling between the embryo and the mother. Since these
structures were malformed in PTBP1 knockouts, mutant embryos
may have been starved and unable to properly communicate with
the surrounding maternal tissue. In all likelihood, restricted supply
and decreased capacity to divide are compounding developmental
problems of the embryos lacking PTBP1 but further experiments
would be required to distinguish between defects in the epiblast
and the extra-embryonic supportive structures.
We have observed that PTBP1 null embryos are able to implant
but then remain small, which was not seen in a recent study
analysing the effect of mouse PTBP1 null mutations in embryos and
embryonic stem cells [39]. That study found that PTBP1 is
expressed both in the trophectoderm and the inner cell mass of the
blastocyst and that no stem cell lines could be established from
homozygous PTBP1 knockout blastocyst unlike from those of the
other genotypes. However, PTBP1 null stem cells could be
generated by viral insertion of a Cre-expressing construct. The
resulting mouse ESCs showed similar levels of Oct4 and Sox2 but
slightly decreased Nanog and Rex1, all markers of the undifferenti-
ated state. This indicates that in these cells a degree of pluripotency
could be maintained even in the absence of PTBP1. However, ESCs
without PTBP1 proliferated 8–12x more slowly than heterozygous
controls due to delayed G2/M progression. These observations fit
Figure 3. Embryos from PTBP1 KO heterozygous parents fall into 2 size categories. Hematoxylin and eosin stained decidual sections of 2
litters were analysed for surface area and structural organisation. Embryos were grouped according to their developmental stage (left) with the
furthest developed having reached neural plate stage but most embryos being at the primitive streak stage. The surface area of the embryos in the
middle section was measured with the Fiji image software and ranked according to size, which turned out as equivalent to stage (right). Presumed
knockouts (red) were significantly smaller than wild-type or heterozygous controls and present in a roughly Mendelian ratio of 3:10 (ratio 0.3 vs. the
expected 0.25). The size of the small embryos might have even been overestimated since it was harder to recognise the embryo in those
implantations. We also encountered 2 decidua with no visible embryonic structures.
doi:10.1371/journal.pone.0016992.g003
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very well with our data on the increasing size gap between null and
control embryos after implantation. Nevertheless, in that study no
homozygous mutants were observed at E6.5 and after. Here, on the
contrary, we detected the very small homozygous embryos after
implantation and analysed their structure. PTBP1 also emerged as
one of the strongest hits from a genome-scale RNAi screen for
regulators of Oct4 [40]. esiRNA targeted against PTBP1 leads to
,50% decrease in Oct4 as well as .60% decrease in Nanog
transcript levels. This correlated with a loss in alkaline phosphatase
staining and a flattening of the characteristically spherical ESC
colonies. Thus, it appears that although PTBP1 is not an absolute
requirement for stemness, it does have a strong positive effect on the
pluripotency of embryonic stem cells.
RNA-binding proteins in embryonic development
The data detailed above [39] together with the present findings
firmly establish PTBP1 as a factor essential for early embryonic
development, in particular due to its necessity for speedy cell
division. PTBP1 joins ranks with several other RNA-binding
proteins that cause severe defects in early embryonic development.
For example, the knockout of SSB, which like PTBP1 contains
RRMs, completely prevents implantation and the generation of
Figure 4. PTBP1 knockout embryos implant but are severely growth-retarded. The small category of embryos from a heterozygous
intercross were identified by PCR and immunofluorescence as PTBP1 knockout embryos. A) PCR products for the stop cassette and PTBP1 intron 2
were separated on agarose gels and scored blindly. 5/5 small embryos were genotyped as homozygous. 15/17 large control embryos were
genotyped as heterozygous or wild-type with 2 false negatives due to the less efficient intron PCR. B) Serial paraffin sections of E7.5 embryos were
stained with hematoxylin and eosin (left column) or labelled with DAPI (middle column) and the PTBP1 antibody (right column). The top row shows a
large embryo (in an oblique section) with strong nuclear PTBP1 staining of the embryo proper (dashed line) and the surrounding tissue. Both small
embryos were characterised by a lack of the nuclear PTBP1 signal while showing nuclear PTBP1 in surrounding, most likely maternal cells.
Interpretative diagrams and a quantification of the embryo section area are shown on the right.
doi:10.1371/journal.pone.0016992.g004
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stem cells from blastocysts [41]. Null embryos for ELAVL1,
composed of 3 RRMs and a SPOC domain, implant and begin
gastrulation but then die between E10.5 and E14.5 due to
placental malformation [42]. Another RRM-containing protein,
TIAR, has a more specific defect, as it is required for survival of
primordial germ cells and the formation of spermatogonia and
oogonia, probably due to its effect on cell division [43].
Splicing or stabilisation
At the current state of the analysis it is not clear which
molecular function of PTBP1 is responsible for the drastic
developmental defects of its null embryos. The aforementioned
stabilising effect of PTBP1 on CU-tract containing mRNAs may
be required to provide enough messenger for protein synthesis
when it is upregulated in the volume growth phase of the embryo
after implantation. On the other hand, the control PTBP1 exerts
on the splicing pattern of embryonic cells may be crucial for the
proliferation of the early embryo. Part of the differentiation
Figure 5. PTBP1 null embryos show defects in yolk sac & placenta development. This figures compares yolk sac and placental structures in
knockout and control embryos. A) Hematoxylin and eosin-stained paraffin sections of an E5.5 wild-type embryo, chosen for its comparable size to the
null mutants, and an E7.5 yolk sac (left) juxtaposed with mutant E7.5 embryos and mutant yolk sacs, respectively (right). Mutants lack the typical
structure of a normal embryo at this stage. If discernable at all they lack a typical yolk sac with a thin Reichert’s membrane in close proximity to
trophoblast giant cells and the decidua. B) Immunofluorescence for collagen 4 on a section of a control E7.5 embryo is shown next to a similar image
from a homozygous embryo. The control embryo shows collagen 4 signal from several basement membranes including the Reichert’s membrane of
the yolk sac. The null mutant, on the other hand, shows an unusually extended area high in collagen 4, not resembling a membrane. Separate
channels for the collagen immunomicroscopy can be seen in Figure S4.
doi:10.1371/journal.pone.0016992.g005
Figure 6. Deletion of PTBP1 leads to the absence of T/brachyury.
The figure compares RT PCR results from normal and mutant embryos
for the presence of a gastrulation marker and a control. RNA purified
from large (L) and small (S) embryos was used as template for reverse
transcriptase (RT) PCR amplification of the primitive streak marker T/
brachyury and of a LacZ control to ensure successful RNA purification.
None of the small PTBP1 KO homozygous embryos showed the
presence of T mRNA while positive for the control RT PCR.
doi:10.1371/journal.pone.0016992.g006
PTBP1 Is Required for Embryonic Development
PLoS ONE | www.plosone.org 8 February 2011 | Volume 6 | Issue 2 | e16992
process is the divergence of splicing programmes. Since the pre-
implantation embryo contains only few different tissues, splicing
patterns are probably similar. After implantation, many different
tissues arise and may require PTBP1 to control exon selection.
Further experiments, for example CLIP [44] to identify the targets
of PTBP1, mRNA decay assays to test for potential stabilising
effects and splice form-sensitive microarrays may clarify these
points. Possibly, even the not yet well-established role of PTBP1 in
binding gene promoter regions may play a role. The main
challenge for these studies will be the very low amount of
homozygous mutant material that can be obtained.
Outlook
The Ptbp1 mutant mouse generated and analysed here demon-
strates how the absence of an RNA-binding protein, involved in
splicing and RNA stability among other functions, can completely
halt embryonic development. It also shows that the paralogues Ptbp2
and Rod1 are not able to compensate for the loss of Ptbp1.
Figure 7. PTBP1 expression in normal and mutant embryos. Comparison of immunofluorescence from PTBP1 and its paralogue PTBP2 in
control and PTBP1 KO embryos at E7.5. The top row shows serial cryosections of a normally sized control embryo stained for PTBP1 (left) and PTBP2
(right). PTBP1 was expressed in most embryonic cells, notably the visceral endoderm and the epiblast, comparable to the LacZ reporter staining in
Figure 2. A strong PTBP1 signal was also observed in decidual nuclei. PTBP2 in controls was mostly expressed in the epiblast and absent from most
decidual nuclei. PTBP1 null embryos (bottom) showed no PTBP1 or PTBP2 signal, displayed here merged with the DAPI signal to reveal the embryo
(dashed line). Again most cells surrounding the embryo displayed a nuclear PTBP1 signal while only very few showed a weak nuclear PTBP2 signal
(arrow).
doi:10.1371/journal.pone.0016992.g007
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Embryonic cells lacking Ptbp1 can divide in principle but do so at a
much slower rate. In addition and possibly linked to the former,
Ptbp1 null embryos have problems with correct differentiation.
With the Yoshida lab allele (loxP-framed exon 1) and our multi-
purpose allele (FRT-framed stop/detection cassette and loxP-
framed exon 3–7) two new PTBP1 alleles have been generated
which can be combined with a wide variety of Cre strains for
conditional deletion. The allele used in this study, in its first stage
before combination with a FLP recombinase, could also be
exploited to detect the activity of the PTBP1 locus in various tissues
during ontogeny as exemplified by our data for embryonic
developmental stage E12.5 and E16.5. Considering the strong
interest in embryonic stem cells and regulation of splicing patterns
these PTBP1 alleles will be an important tool to further dissect the
multiple functions of this nucleic acid-binding protein. More
specifically, the second stage of the multi-purpose allele after
recombinase conversion could be used for the conditional knockout
of PTBP1 in pancreatic b-cells only [45] in order to test the role of
this gene in insulin granule biogenesis and diabetes [18,19,46].
Materials and Methods
Generation of a PTBP1 multi-purpose mutant mouse
allele
The PTBP1 genomic sequence used for the construction of the
mutant allele was based on the male C57BL/6J bacterial artificial
chromosome RPCI24-368K20, obtained from the CHORI’s
BACPAC. Part of PTBP1 was first subcloned and later modified
in several steps via Red/ET recombination (Gene Bridges) in E.
coli bacteria. The final targeting construct was linearised,
electroporated into R1/E 129 mouse stem cells grown on feeders
and selected using HygB. The correct insertion of the targeting
construct into the genome was subsequently confirmed by
Southern blot on genomic DNA and junction PCR over the
homologous recombination arm. The full sequence of the
targeting construct used to modify the PTBP1 locus can be
found in the nucleotide databases like GenBank under the
identifier HM588137 (http://www.ncbi.nlm.nih.gov/nuccore/
307557308).
Generation of PTBP1 KO mice
The verified stem cell clones were selected for morula injection
with a germline transmission rate per embryo of 0/50 and 5/80
for the 2 clones respectively. Chimeras were inbred with C57BL/
6J for 5–8 generations before being intercrossed and analysed. All
animal experiments were conducted in a licensed animal facility in
accordance with the German Animal Welfare Act, following the
guidelines of the European Convention for the Protection of Vertebrate
Animals Used for Experimental and Other Scientific Purposes and approved
by the Regional Council (24-9168.24-1-2003-2).
Genotyping
Adult PTBP1 mutant mice were genotyped from a tail clip after
proteinase K digestion using 2 primer pairs. Pair 1 (forward: 59-
Figure 8. Cell division & apoptosis in mutant embryos. The figure shows control and Ptbp1 null embryo sections at E7.5 immunolabelled for
BrdU (top row) and processed by TUNEL (bottom row). The former is a cell division assay measuring the integration of the nucleotide analogue
bromodeoxyuridine (BrdU). The latter is an apoptosis assay based on terminal deoxynucleotidyl transferase dUTP nick end labelling (TUNEL). Control
embryos (1st column) showed strong BrdU signal especially in the epiblast, the yolk sac area, and the ectoplacental cone while being negative for
TUNEL. Heterozygous decidua were typically BrdU-labelled most strongly in the periphery, visible only in KO1 and cropped in control1 and KO2.
Homozygous mutant embryos showed less (KO1) to no BrdU labelling (KO2) varying with embryo and section. Most null mutants analysed showed
some degree of TUNEL (exemplified by KO3 and KO4). The longest diameter of the embryo is indicated below each panel and the relative sizes of the
panels are indicated with dashed lines.
doi:10.1371/journal.pone.0016992.g008
PTBP1 Is Required for Embryonic Development
PLoS ONE | www.plosone.org 10 February 2011 | Volume 6 | Issue 2 | e16992
CTGTAGCGGCTGATGTTGAA, reverse: ATGGCGAT-
TACCGTTGATGT, product: 299 bp) detects the LacZ reporter
gene and differentiates between wild-type (wt) and heterozygous/
homozygous mice. Pair 2 (CCTCATTTGCTGTCCTGGTT,
CCCTGGTGTCCTGTCATCTT, product 208 bp) binds to
intronic sequences around the insertion site of the stop and
detection cassette and differentiates between hom and wt/het
genotypes.
Due to the small amount of early embryonic tissue, the entire
embryo were used for genotyping at gestational stages before E9.
The embryonic tissue was carefully dissected to avoid contamina-
tion by tissue from the mother and then genotyped as above.
Embryo cryosections and X-gal staining
Gestation was timed according to the morning-after plug check.
Mice were sacrificed after isoflurane narcosis by cervical
dislocation. Uteri were dissected in ice-cold phosphate-buffered
saline. Isolated deciduas or embryos were immersed in 30% (m/v)
sucrose in phosphate-buffered saline (PBS) for 30 min to avoid
cryoartefacts. Samples were then embedded in Tissue-Tek (Sakura
4583), frozen using liquid nitrogen, cut into 10 mm thick sections
and mounted. Samples were fixed in PBS with 0.2% (v/v)
glutaraldehyde, 5 mM EGTA and 0.1 M MgCl2 at 4uC for
10 min. Sections were then washed 3x 5 min in LacZ wash buffer
(PBS with 0.01% sodium deoxycholate, 0.02% NP40 and 2 mM
MgCl2) and incubated overnight in LacZ staining buffer
containing 2.45 mM 5-bromo-4-chloro-3-indoxy-b-D-galactopyr-
anoside (X-gal). The staining buffer was prepared by diluting an
X-gal stock (1g X-gal in 40 ml dimethylformamide) 1:25 in LacZ
wash buffer and adding 5 mM K-ferrocyanide and 5 mM K-
ferricyanide. After removal of the staining solution and 3 PBS
washes, the X-gal staining was allowed to intensify in PBS at 4uC
before mounting and bright field imaging.
Histology and immunohistochemistry
The entire deciduas were fixed in 4% paraformaldehyde
overnight at 4uC, dehydrated and embedded in paraffin. 5 mm
sections were cut, deparaffinised and stained with hematoxylin and
eosin. Serial sections were used for immunodetection of PTBP1.
Antigen retrieval was performed by treatment of the slides with
Tris-EDTA buffer (10 mM Tris Base, 1 mM EDTA Solution,
0.05% v/v Tween 20, pH 9.0) for 40 min. at 95uC. The sections
were then incubated overnight at 4uC with the anti-PTBP1
antibody (Invitrogen, prev. Zymed,#32-4800) or the anti-collagen
IV antibody both diluted 1:200 in PBS. Detection of the primary
antibody was achieved by incubating the sections with a Cy3-
conjugated goat anti-mouse IgG (Jackson Immuno Research
Laboratories) diluted 1:500 in PBS at room temperature for
45 min. Sections were finally mounted with Mowiol (Biovalley)
containing DAPI at 10 mg/ml and imaged with a fluorescence
microscope equipped with DAPI and CY3 filters.
For immunolabelling of embryo cryosections, the decidua was
dissected, embedded in TissueTek OCT and then frozen on dry
ice. 10 mm sections were cut and mounted on glass slides. Sections
were washed with PBS and then blocked by incubation in goat
serum buffer (16% v/v goat serum, 20 mM phosphate buffer at
pH 7.4, 0.45 M NaCl, 0.3% v/v Triton-X-100) at room
temperature for 1 h. Samples were then incubated with the anti-
PTBP1 or anti-PTBP2 antibody (Abnova H00058155-A01)
diluted 1:200 in goat serum buffer at 4uC overnight. Primary
antibodies were detected by incubation with goat anti-mouse
IgG1-Alexa488 (Invitrogen) diluted 1:200 in goat serum buffer and
DAPI at 5 mg/ml at room temperature for 45 min.
Reverse transcriptase PCR
Two E7.5 litters from a heterozygous intercross were dissected in
ice-cold PBS, washed 2x in cold PBS to reduce the risk of maternal
contamination, and extracted using TRIzol (Invitrogen). RNA was
reverse transcribed using SuperScript II (Invitrogen). RT PCR was
performed using T/brachyury primers (forward primer: TCCC-
AATGGGGGTGGCTTGTTCCTG, reverse primer: ACCA-
GAAGACGAGGACGTGGCA; expected product: 474 bp) and a
different set of LacZ primers (forward: CTGGCTACCGGCGAT-
GAGCG, reverse: GATCAGCGGGCGCGTCTCTC, product;
310 bp) and Platinum Taq (Invitrogen). PCR products were
analysed on agarose gels.
BrdU assay
A total of 0.6 mg BrdU/10 g body weight in sterile PBS was
injected into the stomach cavity (IP) of pregnant mice at day 7.
Mice were sacrificed and embryos were dissected out of uterus in
cold PBS 3 hours later. Embryos were immersed in 9%, 18% and
30% w/v sucrose in PBS at 4uC before being embedded in Tissue-
Tek and frozen at 280uC. Blocks were cryosectioned at 8 mm
thickness.
Serial sections were fixed in 4% w/v PFA at 4uC for 30 minutes
and permeabilised in PBS and 0.3% v/v Triton X-100 at RT for
1 hour. Sections were washed 3x 5 minutes with PBS at RT.
2 mol/L HCl treatment was applied to all sections at RT for 25
minutes. Sections were washed 3x 5 minutes with PBS and
blocked with 10% v/v goat serum and 0.3% Triton X-100 in PBS
at RT for 1 hour. Afterwards, they were incubated overnight with
primary antibody (rabbit anti-BrdU, abcam ab6326, diluted 1:500
in blocking buffer). Sections were washed 3x 5 minutes in PBS at
RT and incubated with secondary antibody (AlexaF 555 goat anti-
rabbit, Molecular Probes, diluted 1:500 in blocking buffer) and
DAPI (5 ng/ml) at RT for 1 hour. Sections were washed 3x 5
minutes in PBS at RT and mounted with Mowiol. Images were
made using a Zeiss LSM 510 confocal microscope.
TUNEL assay
Samples were dissected as described above for the BrdU assay.
Serial sections were fixed in 4% w/v PFA at 4uC for 20 minutes
and washed with PBS at RT for 30 minutes. Sections were
permeabilised in 0.1% v/v Triton X-100 for 2 minutes on ice.
Sections were incubated in staining solution (450 ml dUTP-TMR
labelling solution +50 ml terminal transferase solution both from
the Roche in situ cell death detection kit #12156792910 and
added DAPI at 5 ng/ml) at 37uC for 60 minutes. Sections were
briefly rinsed 3x with PBS and mounted in Mowiol. Images were
made using a Zeiss LSM 510 confocal microscope.
Supporting Information
Figure S1 Construction of the PTBP1 multi-purpose
allele. The figure shows the Red/ET homologous recombination
strategy used to construct the PTBP1 multi-purpose allele. A) The
genomic sequence was derived from a bacterial artificial
chromosome (BAC) and subcloned into a more easily handled
bacterial vector. First, the lower loxP site was inserted, selected for
and removed via transient transfection with a Cre-expressing
plasmid. Second, the FRT-framed stop cassette and upper loxP
site were inserted and selected for. B) The verified targeting
construct was cleaved from the plasmid, electroporated into mouse
embryonic stem cells and selected for. (ori - origin of replication;
sA - splice acceptor; IRES - internal ribosome entry site; b-
galactosidase/hygromycin-B fusion; STOP codon; polyA signal;
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recombinase recognition sites: FRT - Flp recombinase; loxP - Cre
recombinase).
(TIFF)
Figure S2 Verification of the effectiveness of the Ptbp1
stop cassette. Transcription stop cassettes, as the one used in
this study, have on occasions been observed to be breached,
resulting in the synthesis of some full-length mRNA [PMIDs
8978605, 9039657, 16575173]. To verify the effectiveness of the
Ptbp1 null allele employed here, we designed primers for the 39
end of Ptbp1 and performed RT PCR on small homozygous and
large heterozygous/wild type embryos at E7.5. We observed that
the 39 UTR of Ptbp1 could be amplified in all large embryos,
while most homozygous embryos showed no product from the 39
Ptbp1 primers. In the few cases (red) were a faint signal could be
observed, null embryos were not well segregated from the
surrounding maternal tissue. The signal is likely to have arisen
from a small number of maternal cells that could not be removed
during the dissection. cDNA quality was confirmed using a tubulin
a1b primer. Primer sequences: Tuba1b cagtgttcgtagacctggaacc &
ctgtggaaaaccaagaagccctg, product 226 bp; Ptbp1 exon 12/13 to
exon 14 acctctccaacatcccgccct & gcaggtggtggttctcgccc, product
198 bp (stop cassette in intron 2).
(TIFF)
Figure S3 Whole-mount LacZ staining of embryos.
Complementing the LacZ staining on sections (Figure 2), this
figure shows whole-mount LacZ staining at E12.5 and E16.5. The
X-gal signal seen here is superficial since the dye could not
penetrate deeply into embryos at these stages. However, due to the
thickness of the sample, areas with weak expression can be
recognised. For example at E16.5 the skin appeared unstained in
the sections while from the whole-mount it became clear that the
reporter was expressed also there.
(TIFF)
Figure S4 Collagen separate channels. This figure shows
the same embryos as in Figure 5b and an additional PTBP1 null
mutant (3rd column). Confocal fluorescence from DAPI and
collagen 4 antibodies is displayed separately. In addition, a
hematoxylin and eosin stained serial section is shown for each of
the 3 embryos. The 2nd row emphasises the aberrant localisation
of collagen 4 in embryos lacking PTBP1 versus those expressing
normal levels.
(TIFF)
Figure S5 Rod1 mRNA is not detected in E7.5 embryos.
Rod1 is a nucleic acid binding protein, paralogous to Ptbp1 and
Ptbp2, and known in yeast to suppress differentiation. To test
whether Rod1 is upregulated in response to the absence of Ptbp1/
2, we performed RT PCR on small homozygous and large
heterozygous/wild type embryos 7.5 days of age. Neither the null
mutants nor the control embryos appeared to express Rod1
mRNA. Efficiency of the Rod1 amplification was confirmed with a
Rod1 cDNA positive control (left); the expected product size is
423/448 bp depending on the Rod1 splice variant. cDNA
synthesis was confirmed using a tubulin a1b control primer pair
(product size 226 bp). We tested 3 other Rod1 primer pairs also
without amplification. This gel shows the products of Tuba1b
primers cagtgttcgtagacctggaacc & ctgtggaaaaccaagaagccctg as well
as Rod1 primers gcggtgagcccgtcaatccc & tctcggtgattggaatactggat.
(TIFF)
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